Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;39(3):967-989.
doi: 10.1007/s10565-021-09658-1. Epub 2021 Nov 13.

Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance

Drishti Jain #  1 , Dinesh Babu Somasundaram #  1 , Sheeja Aravindan  2 , Zhongxin Yu  3 , Ashley Baker  4 , Azadeh Esmaeili  3 , Natarajan Aravindan  5   6   7
Affiliations

Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance

Drishti Jain et al. Cell Biol Toxicol. 2023 Jun.

Abstract

Cluster of differentiation 73 (CD73), a cell surface enzyme that catalyzes adenosine monophosphate (AMP) breakdown to adenosine, is differentially expressed in cancers and has prognostic significance. We investigated its expression profile in neuroblastoma (NB), its association with NB clinical outcomes, and its influence in the regulation of cancer stem cells' (CSCs) stemness maintenance. RNA-Seq data mining (22 independent study cohorts, total n = 3836) indicated that high CD73 can predict good NB prognosis. CD73 expression (immunohistochemistry) gauged in an NB patient cohort (n = 87) showed a positive correlation with longer overall survival (OS, P = 0.0239) and relapse-free survival (RFS, P = 0.0242). Similarly, high CD73 correlated with longer OS and RFS in advanced disease stages, MYCN non-amplified (MYCN-na), and Stage-4-MYCN-na subsets. Despite no definite association in children < 2 years old (2Y), high CD73 correlated with longer OS (P = 0.0294) and RFS (P = 0.0315) in children > 2Y. Consistently, high CD73 was associated with better OS in MYCN-na, high-risk, and stage-4 subsets of children > 2Y. Multivariate analysis identified CD73 as an independent (P = 0.001) prognostic factor for NB. Silencing CD73 in patient-derived (stage 4, progressive disease) CHLA-171 and CHLA-172 cells revealed cell-line-independent activation of 58 CSC stemness maintenance molecules (QPCR profiling). Overexpressing CD73 in CHLA-20 and CHLA-90 cells with low CD73 and silencing in CHLA-171 and CHLA-172 cells with high CD73 showed that CD73 regulates epithelial to mesenchymal transition (E-Cadherin, N-Cadherin, Vimentin), stemness maintenance (Sox2, Nanog, Oct3/4), self-renewal capacity (Notch), and differentiation inhibition (leukemia inhibitory factor, LIF) proteins (confocal-immunofluorescence). These results demonstrate that high CD73 can predict good prognosis in NB, and further suggest that CD73 regulates stemness maintenance in cells that defy clinical therapy.

Keywords: CD73; High-risk neuroblastoma; NT5E; Neuroblastoma prognosis; Stemness maintenance.

PubMed Disclaimer

References

    1. Abbracchio MP, Cattabeni F, Clementi F, Sher E. Adenosine receptors linked to adenylate cyclase activity in human neuroblastoma cells: modulation during cell differentiation. Neuroscience. 1989;30(3):819–25. https://doi.org/10.1016/0306-4522(89)90173-5 . - DOI - PubMed
    1. Alzamely KO, Hajizadeh F, Heydari M, Ghaderi Sede MJ, Asl SH, Peydaveisi M, Masjedi A, Izadi S, Nikkhoo A, Atyabi F, Namdar A, Baradaran B, Sojoodi M, Jadidi-Niaragh F. Combined inhibition of CD73 and ZEB1 by Arg-Gly-Asp (RGD)-targeted nanoparticles inhibits tumor growth. Colloids Surf B Biointerfaces. 2021;197:111421. https://doi.org/10.1016/j.colsurfb.2020.111421 . - DOI - PubMed
    1. American-Cancer-Society. Cancer facts & figures. Atlanta: American Cancer Society 2013:1–64.
    1. Antonioli L, Fornai M, Pellegrini C, D'Antongiovanni V, Turiello R, Morello S, et al. Adenosine signaling in the tumor microenvironment. Adv Exp Med Biol. 2021;1270:145–67. https://doi.org/10.1007/978-3-030-47189-7_9 . - DOI - PubMed
    1. Arab S, Alizadeh A, Asgharzade S. Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment. Clin Exp Med. 2021;21:205–13. https://doi.org/10.1007/s10238-020-00674-9 . - DOI - PubMed

Publication types

LinkOut - more resources